[Assessment of the informative value of neuron-specific enolase determined by the immunoenzyme method]

The diagnostic informative value of measurements of neuron-specific enolase (NSE) in health, pulmonary cancer (including small-cell one), 8 different diseases, and pregnant patients with gestation periods from 5 to 33 weeks was assessed. Comparison of the results in each of these 10 groups with the results in health controls did not reveal any appreciable differences for any of the groups or between the tested groups. The authors consider that NSE measurements cannot be recommended for use at other than cancer institutions.